Diagnostics and management of patients with type 2 myocardial infarction
- Authors: Reznik E.V.1,2,3, Golubev Y.Y.1, Mikhaleva L.M.2,4
-
Affiliations:
- Pirogov Russian National Research Medical University
- City Clinical Hospital №31
- Buyanov City Clinical Hospital
- Research Institute of Human Morphology
- Issue: Vol 23, No 10 (2021)
- Pages: 765-771
- Section: Articles
- URL: https://journals.rcsi.science/2075-1753/article/view/96686
- DOI: https://doi.org/10.26442/20751753.2021.10.201129
- ID: 96686
Cite item
Full Text
Abstract
Myocardial infarction (MI) is an acute myocardial injury (confirmed by increasing|decreasing of cardiac troponin T and/or I) in conditions of proven acute myocardial ischemia, manifested by clinical symptoms of acute ischemia and/or ischemic changes on the ECG. Type 2 MI is a form of MI that is not associated with coronary atherothrombosis, secondary to a condition that results in an imbalance between myocardial oxygen intake and oxygen consumption. Type 2 MI can be caused by coronary artery spasm, coronary microvascular dysfunction, embolism, dissection of coronary arteries, aorta, bradyarrhythmia, tachyarrhythmia, respiratory failure with severe hypoxemia, anemia, blood loss, hypotension/shock of other etiology, severe hypertension, surgical interventions. Type 2 MI accounts for 2–70% of all cases of MI. More often type 2 MI occurs in women, elderly, severe, comorbid patients. Type 2 MI is ST segment elevation MI in 3–24% of patients and non-ST elevation MI in others. Coronary angiography (and autopsy) in type 2 MI reveals coronary atherosclerosis in 25–90%, but there is no coronary artery thrombosis. Mortality in patients with type 2 MI is generally higher than in patients with type 1 MI. This article is devoted to the problem of diagnosis and management of patients with type 2 myocardial infarction.
Full Text
##article.viewOnOriginalSite##About the authors
Elena V. Reznik
Pirogov Russian National Research Medical University; City Clinical Hospital №31; Buyanov City Clinical Hospital
Author for correspondence.
Email: elenaresnik@gmail.com
ORCID iD: 0000-0001-7479-418X
D. Sci. (Med.), Assoc. Prof., Pirogov Russian National Research Medical University, City Clinical Hospital №31, Buyanov City Clinical Hospital
Russian Federation, MoscowYuri Yu. Golubev
Pirogov Russian National Research Medical University
Email: elenaresnik@gmail.com
ORCID iD: 0000-0003-0971-3616
Cand. Sci. (Med.), Pirogov Russian National Research Medical University
Russian Federation, MoscowLiudmila M. Mikhaleva
City Clinical Hospital №31; Research Institute of Human Morphology
Email: mikhalevalm@yandex.ru
ORCID iD: 0000-0003-2052-914X
D. Sci. (Med.), Prof., Research Institute of Human Morphology, City Clinical Hospital №31
Russian Federation, Moscow